24 May 2021Cybin (CYBN.E) new tryptamine patent improves outcome qualityJoseph Morton CYBN.NE Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
